India Metagenomics Market Size, Share, Trends and Forecast by Product, Technology, Application, and Region, 2026-2034

India Metagenomics Market Summary:

The India metagenomics market size was valued at USD 64.0 Million in 2025 and is projected to reach USD 137.8 Million by 2034, growing at a compound annual growth rate of 8.46% from 2026-2034.

The India metagenomics market is experiencing robust growth driven by increasing investments in genomics research and expanding applications across clinical diagnostics and biotechnology sectors. Rising government support through initiatives such as the GenomeIndia project and Bio-E3 Policy is fostering innovation and adoption of advanced sequencing technologies. The growing burden of infectious diseases and the need for rapid pathogen detection are accelerating demand for metagenomics solutions, positioning India as a key growth hub in the Asia-Pacific India metagenomics market share.

Key Takeaways and Insights:

• By Product: Instruments and software dominate the market with a share of 52.6% in 2025, owing to increasing demand for advanced sequencing platforms and integrated analytical tools. Rising research investments and expanding diagnostic applications are fueling adoption across laboratories and healthcare facilities.
   
• By Technology: Sequencing leads the market with a share of 46.3% in 2025. This dominance is driven by technological advancements in next-generation sequencing platforms and growing applications in infectious disease surveillance, microbiome research, and drug discovery across India.
   
• By Application: Infectious disease diagnosis represents the largest segment with a market share of 40.8% in 2025, reflecting the critical need for rapid pathogen identification and antimicrobial resistance profiling in a country with high tuberculosis and tropical disease burdens.
   
• By Region: West India exhibits a clear dominance in the market with 34.9% share in 2025, driven by concentration of pharmaceutical companies, research institutions, and healthcare infrastructure in Mumbai and Pune metropolitan areas.
   
• Key Players: Key players drive the India metagenomics market by expanding product portfolios, improving sequencing accuracy and throughput, and strengthening distribution networks. Their investments in research collaborations, affordability initiatives, and partnerships with academic institutions boost awareness and accelerate adoption across diverse research segments.

The India metagenomics market is growing at a fast pace as the healthcare community, research organizations, and biotech firms are adopting the latest sequencing technology for thorough microbial analysis. The government is providing a significant boost to genomics research by facilitating the development of genomic infrastructure and data repositories in the country. The Indian Biological Data Centre, which was launched as the first national life science data repository in the country, is a testament to the increasing support infrastructure for genomics research. The increasing number of infectious diseases, such as tuberculosis and tropical diseases, is fueling the demand for metagenomics-based diagnostic tools that can simultaneously identify multiple pathogens and resistance markers. The pharmaceutical industry is increasingly adopting metagenomics for the discovery of new drugs from uncultured microbes, widening the scope of application. The combination of declining sequencing costs, enhanced bioinformatics capacity, and favorable government policies is set to propel the India metagenomics market for long-term growth during the forecast period.

India Metagenomics Market Trends:

Integration of Artificial Intelligence with Metagenomics Workflows

The convergence of artificial intelligence and machine learning algorithms with metagenomics sequencing is revolutionizing the detection of pathogens and analysis of microbial communities in India. The use of sophisticated bioinformatics pipelines based on AI is making it possible to perform rapid taxonomic classification, abundance estimation, and functional gene identification in complex samples. Research organizations are adopting automated analytical platforms that can handle large sequencing data with higher accuracy and faster turnaround times.

Expanding Government-Led Genomics Research Programs

Government-sponsored genomics initiatives are reshaping the metagenomics landscape across India, with programs such as the GenomeIndia project and Dare2eraD TB driving large-scale sequencing efforts. The Department of Biotechnology completed whole genome sequencing of 10,000 individuals from diverse Indian populations in January 2025, creating valuable reference datasets. Collaborative networks involving research institutions, medical colleges, and government agencies are strengthening surveillance capabilities for infectious diseases and enabling population-level microbiome studies.

Growing Focus on Clinical Metagenomics for Precision Diagnostics

Clinical metagenomics is gaining momentum in India as healthcare providers recognize its potential for comprehensive pathogen detection in difficult-to-diagnose infections. Hospitals and diagnostic laboratories are adopting metagenomic next-generation sequencing for identifying bacteria, viruses, fungi, and parasites directly from clinical specimens without prior culture requirements. This unbiased approach is particularly valuable for immunocompromised patients and cases of unknown etiology, enabling timely therapeutic interventions and improved patient outcomes across diverse healthcare settings.

Market Outlook 2026-2034:

The market outlook for metagenomics in India is encouraging with technological advancements, government support, and new application areas coming together to provide a conducive environment for growth. Rising partnerships between Indian firms and global leaders in genomics are adding strength to the Indian ecosystem and facilitating technology transfer. Rising awareness about the link between microbiome and health, along with the fall in sequencing costs and advancements in bioinformatics facilities, will continue to fuel the growth of the market. The market generated a revenue of USD 64.0 Million in 2025 and is projected to reach a revenue of USD 137.8 Million by 2034, growing at a compound annual growth rate of 8.46% from 2026-2034.

India Metagenomics Market Report Segmentation:

Product Insights:

• Instruments and Software
• Consumables

Instruments and software dominate with a market share of 52.6% of the total India metagenomics market in 2025.

The instruments and software segment commands the largest share of the India metagenomics market, driven by increasing adoption of advanced next-generation sequencing platforms across research institutions, diagnostic laboratories, and pharmaceutical companies. High-throughput sequencers with improved accuracy and reduced run times are enabling comprehensive microbial community profiling and pathogen detection. The segment benefits from growing investments in genomics infrastructure, with Illumina establishing a Global Capability Center in Bengaluru in 2024, hiring over 200 professionals to support sequencing technology deployment and customer service across the region.

Integrated bioinformatics software solutions are becoming essential components of metagenomics workflows, enabling automated data analysis, taxonomic classification, and functional annotation. Cloud-based analytical platforms are facilitating remote data processing and collaborative research across geographically dispersed teams. The growing complexity of metagenomic datasets and the need for standardized analysis pipelines are driving demand for sophisticated software tools that can handle millions of sequencings reads while maintaining analytical accuracy and reproducibility across different laboratory settings.

Technology Insights:

• Sequencing
• Bioinformatics

Sequencing leads with a share of 46.3% of the total India metagenomics market in 2025.

The sequencing segment dominates the India metagenomics market technology landscape, propelled by rapid technological advancements in next-generation sequencing platforms and declining per-base sequencing costs. Shotgun metagenomic sequencing approaches are gaining preference over targeted amplicon methods due to their ability to capture complete microbial community profiles without primer bias. The Dare2eraD TB initiative, which completed whole genome sequencing of 10,000 Mycobacterium tuberculosis samples by March 2025, demonstrates the growing application of sequencing technologies for national health surveillance programs in India.

Long-read sequencing technologies are emerging as valuable tools for resolving complex genomic regions and improving metagenomic assembly quality in clinical and research applications. Research institutions are increasingly adopting hybrid approaches that combine short-read and long-read sequencing methodologies to achieve comprehensive strain-level resolution and enhanced taxonomic classification accuracy. Real-time sequencing capabilities are enabling point-of-care diagnostics and rapid outbreak response, while portable sequencing devices are expanding access to remote and resource-limited settings across diverse healthcare environments throughout India.

Application Insights:

• Infectious Disease Diagnosis
• Environmental Remediation
• Gut Microbe Characterization
• Biotechnology
• Biofuel
• Agriculture

Infectious disease diagnosis exhibits a clear dominance with a 40.8% share of the total India metagenomics market in 2025.

The infectious disease diagnosis segment leads the India metagenomics market, reflecting the country's substantial burden of communicable diseases and the critical need for comprehensive pathogen detection solutions. Metagenomic next-generation sequencing enables simultaneous identification of bacteria, viruses, fungi, and parasites from clinical specimens without requiring prior culture or specific pathogen hypotheses. India bears a significant proportion of the global tuberculosis burden, and genomic surveillance through programs like the Indian Tuberculosis Genomic Surveillance Consortium is revolutionizing drug resistance monitoring and treatment optimization across healthcare facilities nationwide.

Clinical metagenomics is increasingly deployed for diagnosing difficult infections in immunocompromised patients, central nervous system infections, and cases of fever of unknown origin. The technology offers particular value when conventional diagnostic methods fail to identify causative pathogens, enabling timely therapeutic interventions. Healthcare institutions are recognizing metagenomics as a complementary diagnostic approach that can detect novel, fastidious, and polymicrobial infections while simultaneously characterizing antimicrobial resistance genes for optimal treatment selection.

Regional Insights:

• North India
• South India
• East India
• West India

West India represents the leading segment with a 34.9% share of the total India metagenomics market in 2025.

West India holds the largest geographical market share in the India metagenomics market due to the presence of a large number of pharmaceutical firms, biotech firms, and top-notch research organizations in the Mumbai and Pune regions. The region has an established healthcare infrastructure, talent availability, and efficient logistics systems to support laboratory work. The major diagnostic centers and contract research organizations based in the region are aggressively adopting metagenomics technology for their applications.

The availability of top-notch medical institutions such as Kasturba Hospital and P.D. Hinduja Hospital, which have adopted whole-genome sequencing for tuberculosis drug resistance testing, is a testament to the advanced adoption of genomics technology in the region. Partnerships among academic, government, and corporate organizations are promoting innovation and accelerating the adoption of technology. The region’s favorable business environment and accessibility to international markets make it the prime location for metagenomics research and development activities.

Market Dynamics:

Growth Drivers:

Why is the India Metagenomics Market Growing?

Expanding Government-Sponsored Genomics Research Initiatives

Government-driven genomics projects are offering a significant push to the metagenomics market in India. The GenomeIndia project, led by the Department of Biotechnology, has successfully completed the whole genome sequencing of individuals belonging to various populations in India. The Indian Biological Data Centre has been established at the Regional Centre for Biotechnology in Faridabad, which acts as the national repository for genomic data. The GenomeIndia project aims to provide open access to genomic data. Projects like Dare2eraD TB are using metagenomics for national disease surveillance. Various laboratories across the country are working towards the comprehensive sequencing of tuberculosis samples. Such initiatives are helping to build indigenous capabilities, decreasing dependence on international sequencing facilities, and creating a thriving genomics research community.

Rising Burden of Infectious Diseases Driving Diagnostic Innovation

The substantial burden of infectious diseases in India is accelerating adoption of metagenomics-based diagnostic solutions that offer comprehensive pathogen detection capabilities. India accounts for over 27% of global tuberculosis cases and faces significant challenges from drug-resistant strains that require genomic characterization for effective treatment. Tropical and vector-borne diseases, along with emerging infectious threats, necessitate rapid and accurate identification methodologies that conventional culture-based approaches cannot provide. Metagenomic next-generation sequencing enables simultaneous detection of multiple pathogens and antimicrobial resistance markers from single clinical specimens, reducing diagnostic delays and improving patient outcomes. Healthcare institutions are increasingly recognizing the value of unbiased sequencing approaches for identifying novel and difficult-to-culture pathogens in complex clinical presentations.

Growing Biotechnology Sector Investments and Industry Expansion

Robust growth in India’s biotechnology sector is driving demand for advanced genomics technologies including metagenomics platforms and services. India’s bioeconomy has expanded USD 165.7 Billion in 2024, with projections to reach USD 300 Billion by 2030. The country now ranks twelfth globally in biotechnology and third in the Asia-Pacific region. International genomics companies are establishing local operations to serve the growing market, with Illumina opening a Global Capability Center in Bengaluru and planning to employ over 200 professionals by 2025. Domestic companies such as Mapmygenome are expanding capabilities through strategic acquisitions, including the purchase of Microbiome Insights in May 2025. Increasing venture capital investments in genomics startups and favorable government policies supporting bio-manufacturing are creating a conducive environment for market expansion.

Market Restraints:

What Challenges the India Metagenomics Market is Facing?

High Equipment and Operational Costs

The substantial capital investment required for acquiring next-generation sequencing platforms and maintaining laboratory infrastructure poses significant barriers to widespread metagenomics adoption in India. High consumable costs, including reagents, library preparation kits, and flow cells, add to the overall expenditure, making comprehensive metagenomic analysis expensive for many healthcare facilities and research institutions, particularly those operating with limited budgets.

Shortage of Skilled Bioinformatics Professionals

The absence of skilled personnel in bioinformatics who can interpret complex metagenomic data limits the growth of the market in India. The interpretation of sequencing data demands expertise in computational biology, database management, and clinical correlation, which is still a shortage in many areas. The dynamic nature of analytical tools and software requires constant training, which is a challenge for many learning institutions that are adopting metagenomics technology.

Infrastructure Limitations in Remote Regions

Inadequate laboratory infrastructure, unreliable power supply, and limited internet connectivity in rural and semi-urban areas restrict metagenomics service accessibility across significant portions of India. Sample transportation logistics and cold chain requirements pose additional challenges for specimen collection from remote healthcare facilities. These infrastructure gaps create disparities in access to advanced diagnostic capabilities between metropolitan centers and underserved regions.

Competitive Landscape:

The India metagenomics market has a highly competitive landscape with the presence of global technology giants, Indian genomics firms, and dedicated service providers. Market players are diversifying through innovation, service delivery, and partnerships with research and healthcare organizations. The level of competition is increasing as firms broaden their product offerings, enhance the accuracy and processing capacity of sequencing, and develop comprehensive workflow solutions. Partnerships between technology firms and research organizations are driving innovation and facilitating faster market entry. Firms are investing in customer training, support infrastructure, and local manufacturing to enhance market presence and unlock new opportunities in the clinical, research, and agricultural sectors.

Recent Developments:

• In May 2025, Mapmygenome, a Hyderabad-based AI-driven genomics company, announced the strategic acquisition of Canada’s Microbiome Insights, a global leader in microbial sequencing and bioinformatic analysis. The acquisition includes Microbiome Insights; CAP-accredited laboratory and intellectual property, enhancing Mapmygenomes metagenomics, transcriptomics, and targeted metabolomics capabilities while enabling North American market expansion.

India Metagenomics Market Report Coverage: